Clinical Research Services Turku
Private Company
Funding information not available
Overview
CRST is a well-established, private CRO based in Finland, spun out from the University of Turku in 2014. It leverages deep academic roots and strategic locations to offer early to late-phase clinical trial services, focusing on proof-of-concept studies. With a strong reputation for reliability and high customer retention, it serves a global clientele from leading pharma to small biotechs. The company's expansion to Helsinki in 2020 significantly increased its patient recruitment reach within Finland.
Technology Platform
Integrated clinical research infrastructure with direct access to Turku University Hospital's emergency beds, advanced imaging (PET, fMRI, ultrasound), and safety lab. Expertise in clinical pharmacology and flexible service model for Phase I-IV trials.
Opportunities
Risk Factors
Competitive Landscape
CRST competes in a fragmented global CRO market. It differentiates itself as a specialized, high-quality site and service provider for early-phase trials, particularly in CNS and metabolic diseases, with deep academic ties. It faces competition from large global CROs (e.g., IQVIA, Parexel) with broader networks and from other regional European CROs with similar academic hospital affiliations.